First surgeries for the new PERLA® TL posterior cortical system

Spineart is proud to announce the first surgeries involving PERLA® TL Cortical, the new Posterior Thoraco-lumbar Fixation System.

On January 19th, the first world-wide surgery with the new PERLA® TL Cortical system was a one-level fusion from L4 to L5, performed by Dr. Jeroen Ceuppens at AZ Groeninge in Kortrijk, Belgium. A week later, on January 25th, the first PERLA® TL Cortical case in the US was a two-level fusion from L4 to S1, performed by Dr. Jason Huffman, MD at Queen of the Valley Hospital in Napa, California. 

Dr. Ceuppens said “The system gives a very good tactile feeling when connecting the modular head onto the screw shank. You can feel it when the head is seated onto the screw and the final locking is tactile and audibly confirmed.“

Dr. Huffman commented on the new system that, “The PERLA® TL Cortical system offers simplified, streamlined instrumentation. The modular shanks provided improved visibility and workflow and attaching the modular heads was quick and intuitive. Overall, PERLA® TL Cortical fully addresses the unique demands of the cortical approach and is among the best systems I have used.”

PERLA® TL Cortical, with its dual pitch threads, modular head, cortical trajectory technique, and specific retractor and distractor, is the newest addition to Spineart’s next generation screw platform, PERLA® TL. Further extensions of the PERLA® TL fixation system are expected to be announced during 2021.

The PERLA® TL Platform is under limited release.

Related

Related items
Date - Category Illustration Title Excerpt
  • Corporate
26 September 2025 Plan-Les-Ouates & Zurich (CH) – Antwerp (BE) Spineart (www.spineart.com), a global medtech innovator in advanced spine surgery solutions, today announces a CHF 25 million capital increase backed...
  • Produits
Spineart announces the full-market launch of its SCARLET® AC-Ti secured anterior cervical cage in the United States. Following 510(k) clearance in May 2024, SCARLET® AC-Ti has been extensively evaluated by...
  • BAGUERA® C
Spineart today announces that it has completed a planned interim analysis for its 2-level BAGUERA® C IDE study, which showed that BAGUERA® C, its innovative cervical disc prosthesis, met the...